Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilent Technologies's Total Liabilities for the quarter that ended in Apr. 2026 was €5,081 Mil.
Agilent Technologies's quarterly Total Liabilities
declined
from Oct. 2025 (€5,141.97 Mil) to Jan. 2026 (€5,025.16 Mil) but then
increased
from Jan. 2026 (€5,025.16 Mil) to Apr. 2026 (€5,081.27 Mil).
Agilent Technologies's annual Total Liabilities
increased
from Oct. 2023 (€4,657.35 Mil) to Oct. 2024 (€5,460.26 Mil) but then
declined
from Oct. 2024 (€5,460.26 Mil) to Oct. 2025 (€5,141.97 Mil).
Agilent Technologies Total Liabilities Related Terms
Agilent Technologies Total Liabilities Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Agilent Technologies's Total Liabilities for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies (MIL:1A) has a Total Liabilities of €5,081 Mil as of Apr. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Agilent Technologies and its competitors.
Is Agilent Technologies' Total Liabilities too high?
Agilent Technologies' current Total Liabilities is €5,081 Mil. Overall, Agilent Technologies has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' Total Liabilities compare to NTRA and WAT?
Agilent Technologies' Total Liabilities of €5,081 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Agilent Technologies and its competitors. Agilent Technologies's current Total Liabilities is €5,081 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (MIL:1A) is currently considered Fairly Valued. The stock's GF Value™ is €123.95, compared to a current price of €117.45 — trading 5.2% below its estimated fair value. The current Total Liabilities is €5,081 Mil. Agilent Technologies' overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Agilent Technologies (MIL:1A), the current Total Liabilities is €5,081 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (MIL:1A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of €117.45 is trading 5.2% below its estimated GF Value™ of €123.95.
GuruFocus considers Agilent Technologies to be Fairly Valued.
Key valuation signals for MIL:1A:
Total Liabilities: €5,081 Mil
GF Value™: €123.95 vs. price of €117.45 (5.2% below fair value)
No single metric tells the full story. See the MIL:1A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
70GF Score
Get the complete analysis for MIL:1A
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1A has been successfully added to your 
